|
1
|
Laux CJ, Berzaczy G, Weber M, Lang S,
Dominkus M, Windhager R, Nöbauer-Huhmann IM and Funovics PT: Tumour
response of osteosarcoma to neoadjuvant chemotherapy evaluated by
magnetic resonance imaging as prognostic factor for outcome. Int
Orthop. 39:97–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kubo T, Furuta T, Johan MP, Adachi N and
Ochi M: Percent slope analysis of dynamic magnetic resonance
imaging for assessment of chemotherapy response of osteosarcoma or
Ewing sarcoma: Systematic review and meta-analysis. Skeletal
Radiol. 45:1235–1242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Li XY, Bu J and Xiao T: How to
explain the role of magnetic resonance imaging on evaluating tumour
response of osteosarcoma to neoadjuvant chemotherapy? Int Orthop.
39:1031–1032. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji WP and He NB: Investigation on the DNA
repaired gene polymorphisms and response to chemotherapy and
overall survival of osteosarcoma. Int J Clin Exp Pathol. 8:894–899.
2015.PubMed/NCBI
|
|
5
|
Hagleitner MM, Coenen MJ, Gelderblom H,
Makkinje RR, Vos HI, de Bont ES, van der Graaf WT, Schreuder HW,
Flucke U, van Leeuwen FN, et al: A first step towards personalized
medicine in osteosarcoma: Pharmacogenetics as predictive marker of
outcome after chemotherapy based treatment. Clin Cancer Res.
21:3436–3441. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sarman H, Bayram R and Benek SB:
Anticancer drugs with chemotherapeutic interactions with
thymoquinone in osteosarcoma cells. Eur Rev Med Pharmacol Sci.
20:1263–1270. 2016.PubMed/NCBI
|
|
7
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai
Z: Research progress on the multidrug resistance mechanisms of
osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Zheng H, Shou T, Tang C, Miao K
and Wang P: Effectiveness of multi-drug regimen chemotherapy
treatment in osteosarcoma patients: A network meta-analysis of
randomized controlled trials. J Orthop Surg Res. 12:522017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu XZ and Mei J: Effect and mechanism
analysis of siRNA in inhibiting VEGF and its anti-angiogenesis
effects in human osteosarcoma bearing rats. Eur Rev Med Pharmacol
Sci. 19:4362–4370. 2015.PubMed/NCBI
|
|
10
|
Ahn JH, Cho WH, Lee JA, Kim DH, Seo JH and
Lim JS: Bone mineral density change during adjuvant chemotherapy in
pediatric osteosarcoma. Ann Pediatr Endocrinol Metab. 20:150–154.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Byun BH, Kim SH, Lim SM, Lim I, Kong CB,
Song WS, Cho WH, Jeon DG, Lee SY, Koh JS, et al: Prediction of
response to neoadjuvant chemotherapy in osteosarcoma using
dual-phase (18)F-FDG PET/CT. Eur Radiol. 25:2015–2024. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
1Chang KJ, Kong CB, Cho WH, Jeon DG, Lee
SY, Lim I and Lim SM: Usefulness of increased 18F-FDG uptake for
detecting local recurrence in patients with extremity osteosarcoma
treated with surgical resection and endoprosthetic replacement.
Skeletal Radiol. 44:529–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Avril P, Le Nail LR, Brennan MÁ, Rosset P,
De Pinieux G, Layrolle P, Heymann D, Perrot P and Trichet V:
Mesenchymal stem cells increase proliferation but do not change
quiescent state of osteosarcoma cells: Potential implications
according to the tumor resection status. J Bone Oncol. 5:5–14.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai S, Zhang T, Zhang D, Qiu G and Liu Y:
Volume-sensitive chloride channels are involved in cisplatin
treatment of osteosarcoma. Mol Med Rep. 11:2465–2470. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo J, Glass JO, McCarville MB, Shulkin
BL, Daryani VM, Stewart CF, Wu J, Mao S, Dwek JR, Fayad LM, et al:
Assessing vascular effects of adding bevacizumab to neoadjuvant
chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer.
113:1282–1288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao X, Wang W, Zhang H, Gao P, Fan B,
Huang C, Fu J, Chen G, Shi L, Zhu H, et al: Individualized
chemotherapy for osteosarcoma and identification of gene mutations
in osteosarcoma. Tumour Biol. 36:2427–2435. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JA, Jeon DG, Cho WH, Song WS, Yoon HS,
Park HJ, Park BK, Choi HS, Ahn HS, Lee JW, et al: Higher
gemcitabine dose was associated with better outcome of osteosarcoma
patients receiving gemcitabine-docetaxel chemotherapy. Pediatr
Blood Cancer. 63:1552–1556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katagiri H, Sugiyama H, Takahashi M,
Murata H, Wasa J, Hosaka S and Miyagi M: Osteosarcoma of the pelvis
treated successfully with repetitive intra-arterial chemotherapy
and radiation therapy: A report of a case with a 21-year follow-up.
J Orthop Sci. 20:568–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kleinerman E: Maximum benefit of
chemotherapy for osteosarcoma achieved-what are the next steps?
Lancet Oncol. 17:1340–1342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang X, Jiang Y, Feng L, Chen H, Zhen C,
Ding M and Wang X: Blockade of PI3K/AKT pathway enhances
sensitivity of Raji cells to chemotherapy through down-regulation
of HSP70. Cancer Cell Int. 13:482013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chatterjee M, Andrulis M, Stühmer T,
Müller E, Hofmann C, Steinbrunn T, Heimberger T, Schraud H,
Kressmann S, Einsele H, et al: The PI3K/Akt signaling pathway
regulates the expression of Hsp70, which critically contributes to
Hsp90-chaperone function and tumor cell survival in multiple
myeloma. Haematologica. 98:1132–1141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boon E, van der Graaf WT, Gelderblom H,
Tesselaar ME, van Es RJ, Oosting SF, de Bree R, van Meerten E,
Hoeben A, Smeele LE, et al: Impact of chemotherapy on the outcome
of osteosarcoma of the head and neck in adults. Head Neck.
39:140–146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan T, Li X, Xie W, Jankovic J and Le W:
Valproic acid-mediated Hsp70 induction and anti-apoptotic
neuroprotection in SH-SY5Y cells. FEBS Lett. 579:6716–6720. 2005.
View Article : Google Scholar : PubMed/NCBI
|
